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Proliferation of alveolar type II pneumocytes, the multipotent stem cells of the alveoli, has been implicated in the development of lung
adenocarcinoma. Hydrogen peroxide (H2O2), a potent promoter of signaling cascades, can mediate the transmission of many intracellular
signals including those involved in cell proliferation. In this study using rat primary type II pneumocytes, we demonstrate that H2O2
significantly increases mitosis through a pathway that includes cyclin-dependent kinase 2 (Cdk2); importin-a, a nuclear trafficking regulator;
and nuclear mitotic apparatus protein (NuMA), an essential component in mitotic spindle pole formation. Upon H2O2 treatment, Cdk2 is
phosphorylated at position thr-160 leading to increases in importin-a and NuMA protein levels and resulting in a significant increase of G2/M
phase in a roscovatine-dependent manner. Type II pneumocytes transfected with NuMA cDNA also show significant increases in G2/M
phase, NuMA, Cdk2 thr-160 and importin-a expression. These effects were prevented by catalase. These results demonstrate that H2O2
orchestrates a complex signaling network regulating S phase entry, nuclear trafficking and spindle pole formation through activation of Cdk2,
importin-a, and NuMA. This pathway is essential for H2O2-induced mitosis in type II pneumocytes.
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Eukaryotic cells respond to increased concentrations of
hydrogen peroxide (H2O2) by triggering a variety of
cellular programs, many of them affecting the cell cycle.
It has been shown that endogenously produced H2O2 has
mitogenic properties [1,2]. Intracellular H2O2 increases
rapidly in cells treated with growth factors [3–5]. Addition
of H2O2 to the culture medium triggers intracellular
signaling cascades involved in cell proliferation by activat-0167-4889/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0167-4889(03)00044-2
Abbreviations: H2O2, hydrogen peroxide; Cdk2, cyclin-dependent
kinase 2; NuMA, nuclear mitotic apparatus protein; MAPK, mitogen-
activated protein kinase; DMEM, Dulbecco’s modified Eagle’s medium;
FBS, fetal bovine serum; PVDF, polyvinylidene-difluoride
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(B. Gonza´lez-Flecha).ing the epidermal growth factor receptor/ErB-1 [6], the
platelet-derived growth factor receptor [7], and several
mitogen-activated protein kinases (MAPKs) including the
p21 Ras-MAPK, the extracellular signal-regulated protein
kinase (ERK), the c-Jun N-terminal kinase (JNK) and the
p38 kinase [8]. Also, H2O2 can activate tyrosine kinases
associated with growth factor receptors [9]. Increases in
intracellular H2O2 were detected in some human tumor
cell lines [10] and its production from mitochondria
appears to be a requirement for tumor viability and growth
[11,12].
Alveolar type II pneumocytes play a major role in the
normal homeostasis and repair of the lung epithelium. The
alveolar epithelium is a major target for oxidant injury and
its repair following injury depends on the ability of type II
pneumocytes to proliferate and differentiate [13]. Analysis
of type II pneumocyte markers indicates that the majority of
human adenocarcinomas develop in cells with a type II
phenotype [14]. Conditional expression of oncogenic K-Ras
G12D, a variant strongly associated with human adenocar-
cinoma, in the lung leads to tumoral development in cellsed.
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more, overexpression of oncogenic K-ras leads to increase
of H2O2 and cell proliferation [13].
Although a role of H2O2 in mitogenic signaling is
strongly suggested, neither its potential role as a mitogen
in alveolar epithelial cells nor the pathways of regulation of
type II cell proliferation by oxidants have been elucidated
yet. Previous studies on models of lung toxicity by hyper-
oxia indicate cyclin-dependent kinase 2 (Cdk2) as a critical
target for oxidant-dependent cell cycle regulation in type II
pneumocytes [13,16]. Progression through the cell cycle
depends on the sequential assembly and activation of key
regulators of the cell cycle machinery, such as the serine/
threonine Cdks [16]. The activity of the Cdks is controlled
by their association with cyclins and Cdk inhibitors, which
include their activation through threonine phosphorylation
[16,17]. Cdk2, a member of the protein kinase family which
orchestrates the orderly progression of the eucaryotic cell
cycle [18], also plays a key role from late G1 to late G2
phase [19] governing the initiation, progression, and com-
pletion of cell cycle events [16].
Nucleocytoplasmic trafficking at the appropriate time as
well as proper spindle pole assembly are also critical
regulatory steps in the control of mitosis [20], however,
their possible regulation by oxidants has never been inves-
tigated. Importin-a is a soluble cytosolic receptor that
recognizes classical nuclear localization signals on the
nuclear pore complex [20,21] facilitating protein transport
[22]. Importin-a facilitates the nuclear translocation of
critical cell cycle regulators, including Cdk2 and nuclear
mitotic apparatus protein (NuMA) [23], a 236 kDa protein
essential for the formation of spindle poles during mitosis
[24–28].
The main goal of the present study was to determine the
involvement of Cdk2, importin-a and NuMA protein in the
signaling pathway implicated in H2O2-induced mitosis in
type II pneumocytes. These studies provide new insights
into the mechanism by which H2O2 regulates mitosis in this
cell type.2. Materials and methods
2.1. Materials
Glucose oxidase was purchased from Sigma (St. Louis,
MO); catalase and roscovatine were from Calbiochem (San
Diego, CA), Cell Proliferation Reagent WST-1 from Roche
Diagnostics/Boehringer Mannheim Co. (Indianapolis, IN),
Amplex Red hydrogen peroxide/peroxidase assay kit from
Molecular Probe (Eugene, OR), elastase solution from
Worthington Biochem. Co. (Lakewood, NJ), and Dulbec-
co’s modified Eagle’s medium (DMEM) and vitamins from
Cellgro (Herndon, VA). Polyclonal antibodies against phos-
phorylated thr-160 of Cdk2 and against non-phosphorylated
Cdk2 were from Cell Signaling (Beverly, MA). Polyclonalrabbit antibodies against human importin-a [24], were a gift
from Dr. Karsten Weis (University of California, Berkeley,
CA). Monoclonal mice antibodies against human NuMA
were from BD Bioscience (San Diego, CA). Horseradish
peroxidase conjugated rabbit polyclonal secondary antibod-
ies were from Cell Signaling, and mice monoclonal secon-
dary antibodies from BD Bioscience. The NuMA-pGW1
plasmid containing the 2101 bp coding region of the human
wild-type NuMA cDNA and the pGW1 vector [26,29] were
generous gifts from Dr. Andreas Merdes (Wellcome Trust
Center for Cell Biology, University of Edinburgh, Scotland,
UK).
2.2. Cell culture
Primary alveolar type II pneumocytes were isolated from
pathogen-free Sprague–Dawley rats (180–220 g) as pre-
viously described [30,31]. Briefly, rats were anesthetized
with sodium pentobarbital (50 mg/kg body weight) and the
heart and lungs were rapidly removed. Lungs were perfused
via the pulmonary artery, lavaged and incubated with
elastase solution (30 U/ml) for 20 min at 37 jC. The tissue
was then minced and filtered through sterile filters of 120
and 20 Am nylon mesh. Type II cells were purified by
differential adherence to IgG-coated plates and suspended in
DMEM containing 10% fetal bovine serum (FBS), 1%
vitamins, 2 mM glutamine, 40 mg/ml gentamicin, 100 U/
ml penicillin and 100 Ag/ml streptomycin. Viability of the
final preparation, assayed by exclusion of Trypan blue, was
higher than 90%. Type II pneumocytes purity, evaluated
after Papanicolaou staining [31], was higher than 95%. Cell
were plated at 0.2106 cm2 and grown at 37 jC with 5%
CO2 in supplemented DMEM. After 24 h, adherent cells
(20% of the original inoculum) were washed with DMEM to
remove unattached cells and switched to 1% FBS. Type II
pneumocytes (30–50% confluency) were treated with 300
nM catalase prior to the addition of glucose oxidase, or
catalase plus 5 or 20 mU/ml glucose oxidase (3.5F0.5 and
10.5F0.6 AM H2O2/first hour, respectively). The Cdk2
inhibitor roscovatine (20 nM) was added to the culture 1
h prior to the addition of glucose oxidase.
2.3. H2O2 assay
The Amplex Red reagent (10-acetil-3,7-dihydroxyphe-
noxazine) was used for the determination of concentrations
H2O2 in the culture medium [32] of control cells, cells
treated with glucose oxidase 5 or 20 mU/ml, cells treated
with catalase alone, and catalase plus glucose oxidase 5 or
20 mU/ml. Briefly, 50 Al of cell culture supernatants were
mixed with 50 Al of Amplex Red and incubated for 30 min
at room temperature in 96-well tissue culture plates (Becton
Dickinson, Franklin Lakes, NY). For these determinations,
supplemented DMEM medium without phenol red was
used. Appropriated dilutions were made for each sample,
so that the readings would fit the calibration curve. H2O2
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dation of Amplex Red with H2O2 and converted to colored
and fluorescent oxidation product resorufin. Its intensity was
measured at 560 nm absorbance using a microplate reader
(Molecular Devices, V-max-kinetic microplate reader, Sun-
nyvale, CA) after 1, 8 and 24 h.
2.4. Cell proliferation assay
Cell proliferation in the presence or absence of the
catalase or glucose oxidase was determined using the Cell
Proliferation Reagent WST-1 (tetrazolium salt) [33–35].
Briefly, cells were cultured in supplemented DMEM with-
out phenol red (100 Al) in flat-bottomed 96-well tissue
culture plates at density of 5104/well at 37 jC with 5%
CO2 for 8 or 24 h. At the indicated times, 10 Al of the WST-
1 reagent was added to each well and incubated in a
humidified atmosphere for 1 h. The absorbance of the stable
formazan product in viable cells (tetrazolium salt WST-1
was cleaved by mitochondrial dehydrogenases) was meas-
ured at 450 nm using a colorimetric microplate reader.
2.5. Immunoblotting
Total cell lysates (100 Ag protein/lane) were electro-
phoresed in SDS-8% polyacrylamide gels and transferred
to polyvinylidene-difluoride (PVDF) membranes (BioRad,
Hercules, CA). After blocking with 5% non-fat milk in
TBS-T (50 mM Tris–HCl pH 8.0, 150 mM NaCl and 0.05%
Tween 20) the membranes were probed with the indicated
primary antibodies and horseradish peroxidase-conjugated
affinity-purified secondary antibodies. Proteins were visual-
ized with an enhanced chemiluminescence detection system
(Enhanced Luminal Reagent NEN, Life Science Products,
Boston, MA). Primary and secondary antibodies were used
at dilutions of 1:1000 and 1:20000, respectively.
2.6. Transfection
Type II pneumocytes were transiently transfected with a
NuMA-pGW1 construct or the pGW1 control vector [29]
using the LipofectAMINE protocol (GIBCO Life Technol-
ogies, Carlsbad, CA). Transfection efficiency (f50–55%)
was assayed by co-transfection with green fluorescent
protein GFP-pGW1 and detection of positive green fluo-
rescent cells 24 h after transfection. Cells were lysed and
immunoblotted for detection of phosphorylated Cdk2 thr-
160, importin-a and NuMA.
2.7. Flow cytometry
Type II pneumocytes were harvested by trypsinization
for cell cycle analysis. Cells were fixed in 70% ethanol,
washed in 30% ethanol for 2 min, pelleted and resuspended
in 0.05% BSA/PBS for cell cycle analysis. Cellular DNA
was stained with propidium iodide (50 Ag/ml) in thepresence of 40 Ag/ml RNA-ase for 30 min at room temper-
ature and the DNA content per cell was analyzed by flow
cytometry (Coulter-EPICS-ELITE-ESP Flow Cytometry
System, Miami Lakes, FL). Cell cycle phases (G1, S, and
G2/M) were detected and analyzed using the Advanced
DNA multicycle analysis software (Phoenix Flow Systems,
San Diego, CA). Apoptotic cells were identified as the sub-
Go/G1 peak of the DNA content profiles.3. Results
3.1. H2O2 is required for mitosis of type II pneumocytes
Metabolic generation of low levels of H2O2 is required
for the growth of a variety of immortalized cell types in
culture [1]. To determine whether changes in intracellular
H2O2 could exert a regulatory function on cell proliferation
in type II pneumocytes, primary cultures were treated with
catalase (300 nM) or with defined fluxes of H2O2 and
assessed for cell cycle progression and proliferation 24 h
later.
Scavenging of endogenous H2O2 by addition of extrac-
ellular catalase led to a significant (P<0.0001) 3-fold
decrease in the percentage of type II cells in the G2/M
phases (Fig. 1A) and in cell proliferation (P<0.001) (Fig.
1B). The inhibition of type II pneumocytes mitosis by
catalase was specifically due to scavenging of H2O2 since
treatments with heat-inactivated enzyme did not produce
any effects on cell cycle progression (control=6.2F0.6% in
G2/M phase; catalase=2.2F0.5% in G2/M phase; inactivated
catalase=6.4F0.6% in G2/M phase).
The effects of glucose oxidase treatment on type II cell
mitosis were specifically due to H2O2. Addition of heat-
inactivated glucose oxidase to primary cultures of type II
pneumocytes did not increase the percentage of cells in G2/
M (catalase=2.1F0.5% G2/M phase; catalase+inactivated
glucose oxidase=2.0F0.4% in G2/M phase; catalase+glu-
cose oxidase 20 mU/ml=10.0F1 in G2/M phase).
The ability of type II pneumocytes to proliferate was
rescued upon addition of an exogenous source of H2O2, the
glucose/glucose oxidase system. Reintroduction of H2O2 (5
or 20 mU of glucose oxidase) in cells pretreated with
catalase significantly increased mitosis (P<0.0001) by 3-
and 4.5-fold, respectively (Fig. 1A) and cell proliferation
(P<0.001) by 4- and 9.7-fold (Fig. 1B). These treatments
yieldedf3- and 10-fold increases in H2O2 (for cells treated
with catalase plus glucose oxidase 5 and 20 mU/ml,
respectively), with respect to untreated cells (Fig. 1D)
(control value: 1.1F0.3 AM/h in agreement with a previous
report [30]). On the other hand, treatment with the same
amounts of glucose oxidase in the absence of catalase lead
to significant f5- and 15-fold increases in H2O2, and was
associated with significant decreases (P<0.001) in G2/M
cell numbers (Fig. 1A) and cellular proliferation (P<0.005)
(Fig. 1B).
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glucose oxidase in the presence of catalase did not lead to
increases in the percentage of apoptotic cells, whereas
addition of glucose oxidase alone lead to significant
(P<0.001) increases in cellular apoptosis (Fig. 1C).
The differences in the responses to glucose oxidase alone
and glucose oxidase in the presence of catalase are likely to
be due to the more controlled fluxes of H2O2 produced in
the presence of a detoxification system (catalase), as illus-
trated by the time courses of H2O2 release shown in Fig. 1D.Glucose oxidase treatment increases H2O2 concentrations in
a time-dependent manner both in the absence or presence of
catalase (Fig. 1D). However, in the absence of catalase, the
amount of H2O2 accumulated over 1, 8 and 24 h was
approximately twice of that measured in cells pretreated
with catalase (Fig. 1D).
3.2. H2O2 signaling via Cdk2
Cdk2 kinase plays a critical role in the oxidant-dependent
cell cycle arrest produced by in vitro exposure of lung
epithelial cells to hyperoxia [16]. To elucidate the signaling
pathway by which H2O2 increases mitosis in type II
pneumocytes, we evaluated the effects of H2O2 on Cdk2
activation by measuring Cdk2 phosphorylation in type II
pneumocytes incubated with catalase or catalase/glucose
oxidase (Fig. 2). Increased expression of phosphorylated
Cdk2 thr-160 was observed 5 h after glucose oxidase treat-
ment, and that expression started to decline at 8 h. Removal
of endogenous H2O2 by addition of extracellular catalase
decreased the levels of phosphorylated Cdk2 thr-160, the
active form of this kinase, without altering the total level of
Cdk2 expression (Fig. 2).
3.3. H2O2 signaling via importin-a
Nucleocytoplasmic trafficking of Cdk/cyclin complexes
at the appropriate times is essential for cell cycle control
[36]. CyclinE/Cdk2 complexes are imported into the nuclei
via direct interaction with importin-a, the adaptor subunit of
the importin-a/b heterodimer [37]. We have tested the effect
of H2O2 on importin-a by measuring the importin-a protein
levels in cells treated with catalase and glucose oxidase (Fig.
3). Removal of H2O2 by addition of catalase to the extrac-
ellular medium significantly decreased importin-a levels,
whereas increases in H2O2 lead to a time-dependent increase
in importin-a with maximal values reached 8 h after theFig. 1. H2O2 increases mitosis in type II pneumocytes. Primary cultures of
type II pneumocytes were treated with either glucose oxidase (GO) (5 or 20
mU/ml: GO 5 or GO 20, respectively), catalase (300 nM), or catalase plus
glucose oxidase (Cat+GO 5 and Cat+GO 20, respectively). (A) Cell cycle
position was determined 24 h after treatment. G2/M phase values are
expressed as meanFstandard deviation (S.D.) of six experiments. All
means are statistically different ( P<0.0001) except for the control and
catalase+GO 5 groups. (B) Cell proliferation was assessed 24 h after
addition of GO, catalase or catalase plus GO to the culture media. Values
are expressed as meanFS.D. of three experiments. Cell proliferation was
significantly decreased ( P<0.005) in cells treated with GO 20, and
significantly increased ( P<0.001) in cells treated with catalase+GO 20,
with respect to control untreated cells. (C) The percentage of apoptotic type
II pneumocytes was estimated from the sub-G1 peak 24 h after treatment.
Values are expressed as meanFS.D. of six experiments. Treatment with GO
5 and GO 20 caused significant ( P<0.001) increase in cell apoptosis. (D)
H2O2 concentrations in the culture medium 1, 8 and 24 h after treatment.
Values are expressed as meanFS.D. of three experiments. Glucose oxidase
treatment in the presence or absence of catalase lead to significant
( P<0.001) and time-dependent accumulation of H2O2 in the culture
medium.
Fig. 2. H2O2 signaling via Cdk2. Primary type II pneumocytes were treated
with 300 nM catalase or catalase plus 20 mU/ml glucose oxidase (GO) as in
Fig. 1. After 5 and 8 h of treatment, cells were harvested and protein
extracts were analyzed for phosphorylated Cdk2 thr-160 (pCdk2). Non-
phosphorylated Cdk2 was used as loading control. The data shown in this
figure is representative of three experiments.
Fig. 4. NuMA over-expression increases mitosis in a catalase-dependent
manner. (A) Primary type II pneumocytes were treated with 300 nM
catalase or catalase plus 20 mU/ml glucose oxidase (GO) as in Fig. 1. After
24 h of treatment, cells were harvested and protein extracts were analyzed
for NuMA protein, importin-a, and phosphorylated Cdk2 thr-160 levels.
Non-phosphorylated Cdk2 was used as loading control. (B) Primary type II
pneumocytes were transiently transfected with wild-type NuMA cDNA and
assessed for DNA content per cell after 24 h. Bars represent the mean
values of three experimentsFS.D. (C) NuMA protein, phosphorylated
pCdk2 thr-160 and importin-a levels in type II pneumocytes transfected
with NuMA cDNA. The vector pGW1 was used as a control. The data
shown in this figure is representative of three experiments.
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regulation of importin-a (Fig. 3) reaches maximal values 3
h after Cdk2 phosphorylation (Fig. 2), suggesting that Cdk2
is upstream of importin-a in the signaling pathway induced
by H2O2.
3.4. NuMA cDNA directly increases mitosis in a catalase-
dependent manner through the Cdk2/importin-a pathway
Importins also facilitate the nuclear translocation of other
critical cell cycle regulators such as the NuMA protein [23]
essential for the formation of spindle poles during mitosis
[24,25]. We therefore wanted to determine whether the
H2O2-dependent changes in importin-a levels had an impact
on NuMA protein. We found that increases in the rates of
H2O2 production up-regulate NuMA protein levels (Fig.
4A) with maximal values 24 h after the addition of glucose
oxidase. However, at this time point, the levels of phos-
phorylated Cdk2 thr-160 and importin-a returned to control
levels (Fig. 4A). To confirm the regulatory function of the
increased NuMA protein levels produced by H2O2 in our
model (Fig. 4A), we transiently transfected primary type II
pneumocytes with wild-type NuMA cDNA or empty vector
(Fig. 4B,C); 24 h after transfection, cells were analyzed for
cell cycle position (Fig. 4B). Our data show that increased
expression of NuMA, leads to significant (P<0.0001) in-Fig. 3. H2O2 signaling through importin-a. Primary type II pneumocytes
were treated with 300 nM catalase or catalase plus 20 mU/ml glucose
oxidase (GO) as in Fig. 1. After 5 and 8 h of treatment, cells were harvested
and protein extracts were analyzed for importin-a protein. Non-phosphory-
lated Cdk2 was used as loading control. The data shown in this figure is
representative of three experiments.creased percentage of cells in G2/M (Fig. 4B), suggesting
increased proliferation.
We then wanted to determine if NuMA overexpression
activates the same mitogenic pathway triggered by H2O2.
We first investigated the requirement for H2O2 in NuMA-
dependent signaling by adding catalase to the culture
medium. Strikingly, the pro-mitogenic effects of NuMA
were prevented by catalase (Fig. 4B, P<0.0001) confirming
that endogenous H2O2 is essential for cell proliferation. We
then looked for NuMA-dependent regulation of Cdk2 and
importin-a. As in the cells treated with glucose oxidase,
type II pneumocytes transfected with NuMA cDNA showed
increased NuMA protein, which were accompanied by
increased importin-a protein levels and increased phos-
phorylated Cdk2 thr-160 (Fig. 4C).
3.5. H2O2 increases mitosis in a roscovatine-dependent
manner through the Cdk2/importin-a/NuMA pathway
The time course of increase in Cdk2 phosphorylation
(Fig. 2), and in importin-a (Fig. 3) and NuMA protein levels
(Fig. 4), suggested a sequential activation of these cell cycle
regulators in type II pneumocytes exposed to increased rates
of H2O2 production. To elucidate the effect of H2O2 on
Fig. 5. H2O2 increases mitosis in a roscovatine-dependent manner. Cells
were treated as described in Fig. 1 in the presence or absence of 20 nM
roscovatine. After 5, 8 or 24 h of treatment, cells lysates were analyzed in
different blots of each time point for phosphorylated Cdk2 thr-160 (pCdk2)
at 5 h, importin-a at 8 h, and NuMA protein at 24 h. Intact type II
pneumocytes were analyzed for cell cycle position. Bars represent
meanFS.D. of three experiments.
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mine whether this effect is integrated in one pathway, we
used roscovatine, a specific inhibitor of Cdk2 phosphoryla-
tion to affect this pathway. Type II pneumocytes treated with
20 nM roscovatine [16], prior to the addition of glucose
oxidase showed attenuated increases in importin-a and
NuMA protein levels, as compared with cells that did not
receive roscovatine (Fig. 5). The inhibition of Cdk2 activa-
tion was sufficient to prevent H2O2-induced increases in
type II pneumocytes mitogenesis (Fig. 5, P<0.0001). These
findings strongly suggest that Cdk2 is upstream of importin-
a and NuMA protein in this pathway and that is essential for
H2O2-dependent mitosis.4. Discussion
Although much effort has been devoted to the study of
cell cycle regulation in type II pneumocytes induced to
proliferate by in vitro treatment with growth factors, the
potential role of H2O2 as mitogen for lung epithelial cells
and the pathways of regulation of type II cell proliferation
by H2O2 have not been elucidated yet. Here, we show that
metabolic production of H2O2 is required for type II
pneumocyte mitosis. Furthermore, we found that supra-
physiologic, but non-toxic, increases in the rates of H2O2production exert mitogenic effects in this cell type and that
H2O2 signaling operates through the Cdk2, importin-a,
NuMA pathway. In agreement with the data previously
reported by Leslie et al. [38], we found that primary type
II pneumocytes from adult normal rats proliferate slowly,
with f6% of cells in G2/M phase. We found that removal
of endogenous H2O2 decreases the percentage of cells in G2/
M 3-fold, and reintroduction of H2O2 increases mitosis 3-
and 4.5-fold. These increases are similar or even higher than
those observed in type II pneumocytes freshly isolated
during the peak of recovery from acute hyperoxic lung
injury [39], or in primary type II cells stimulated by keratin
growth factor (KGF) on Matrigel surfaces [40].
Progression through the different phases of the cell cycle
is under the control of specific cyclins and cyclin kinases
[41]. Progression through the G1 phase of the cell cycle and
the G1-S transition indicates cell commitment to a round of
DNA synthesis and is regulated by cyclinE/Cdk2, cyclinD/
Cdk4, and cyclinD/Cdk6. The S phase and the S/G2
transition are under the control of cyclinA/Cdk2 and the
G2/M transition, which indicates commitment to cell divi-
sion, is regulated by the cyclin B/cdc2 complex [42].
Increased expression of cyclins A, D1, D2, and cdc2 have
been reported in type II pneumocytes stimulated with KGF
on Matrigel matrices [40]. These changes were associated
with increased pRB phosphorylation and increased DNA
synthesis and proliferation [40]. Activation of cdk1 and
cdk4 have been shown in proliferating type II pneumocytes
[42]. Most of the evidence available on the role of H2O2 in
cell cycle control is derived from studies of H2O2 toxicity.
Toxic increases in H2O2 concentrations such as those
occurring in association with hyperoxia have been shown
to inhibit cyclinE/Cdk2 kinase activity in immortalized rat
type II pneumocytes [43]. The mechanism of inhibition
involves increased binding of the cyclin kinase inhibitor
p21 [44]. Studies using A549 lung adenocarcinoma cells
confirmed that in vitro exposure to hyperoxia inhibits
proliferation of this cell type through a p21-dependent G1
arrest and further showed a p21-independent S phase arrest
[45]. We found that phosphorylation of Cdk2 thr-160
precedes H2O2-induced mitosis in primary cultures of type
II pneumocytes. In agreement with previous results from
Buckley et al. [40], we found no change in Cdk2 expression
in proliferating type II pneumocytes indicating that the
regulation of Cdk2 activity in this cell type does not require
transcriptional, but post-translational modifications. Taken
together, these data indicate that cyclinE/Cdk2 complex
integrates signals from G1/S promoting and checkpoint
pathways, being a nodal point for dual control of prolifer-
ation in cycling cells, and growth arrest in response to
genotoxic stresses and confirms that the G1/S transition is
a critical point for oxidant-dependent cell cycle control in
lung epithelial cells.
We demonstrated that H2O2 mitogenic signals involve
up-regulation of importin-a, an adaptor subunit of the
importin a/h transporter complex. Several reports indicate
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dulin, the Drosophila homolog of human importin-a1/Rch1,
is differentially expressed and transported in and out of the
nucleus during cell cycle and larval development [46,47].
Although no evidence has been published showing that
transcriptional or post-transcriptional control of importin-a
have regulatory roles on cell proliferation, several lines of
evidence strongly suggest this. Azuma et al. [48] reported
phosphorylation of Srp1, the importin-a analog in S. cer-
evisiae. Increased expression of importin-a has been found
in two independent rat models of diabetes mellitus, a disease
that includes proliferative cellular events [49]. However,
impairment of importin-a-mediated transport by deletion of
importin-a at the nuclear localization signal leads to sig-
nificant increases in p21 mRNA levels and apoptosis [50].
The increases in importin-a levels found in our model in
association with increased proliferation indicate an activa-
tion of nucleocytoplasmic trafficking is required for cell
cycle control in type II pneumocytes.
Importins facilitate nuclear translocation of cell cycle
regulators such as NuMA protein, but they do not have role
in NuMA assembly of the spindle [23]. NuMA protein is
essential for the proper assembly of spindle poles in
preparation for cell division. NuMA is transported and
reside in the nucleus during interphase, but rapidly redis-
tributes to the separating centrosomes during early mitosis
upon nuclear envelope breakdown [26]. The function and
distribution of NuMA during the cell cycle is regulated by
several mechanisms, which include activation through p34/
Cdc2-dependent phosphorylation [27] and Ran-dependent
regulation of the interaction between NuMA and importin-h
[28]. We found that H2O2 increases the expression of Cdk2
thr-160, importin-a, and NuMA protein, and that up-regu-
lation is enough to drive increased proliferation of type II
pneumocytes. The function and distribution of NuMA
during the cell cycle is regulated by several mechanisms,
which include activation through p34/cdc2-dependent phos-
phorylation [19], and through Ran-dependent regulation of
the interaction between NuMA and importin-h [28]. Our
observation that transcriptional regulation of NuMA can
also regulate NuMA activity during cell proliferation is in
agreement with the findings by other groups that expression
of NuMA is restricted to proliferating cells [51,52]. Fur-
thermore, these investigators found that in cells where
NuMA protein was detectable, its protein level correlates
positively with the levels of expression of proliferation
markers, such as the Ki-67 antigen [52], and negatively
with the culture time and degree of confluency [51,52].
Our data shows a coordinated regulation of Cdk2 phos-
phorylation, importin-a and NuMA protein expression in
type II pneumocytes exposed to increased rates of H2O2
production. Further experimentation is warranted to estab-
lish whether H2O2 directly regulates multiple signaling
proteins in the cell cycle control machinery, or if the
observed effects are due to regulation of G1/S entry fol-
lowed by signaling related to other phases.These studies provide insight into the control of S phase
entry, nuclear trafficking, and spindle pole formation in type
II pneumocyte trough the Cdk2/importin-a/NuMA pathway
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